136 related articles for article (PubMed ID: 19230771)
1. Stents as sole therapy for oesophageal cancer: a prospective analysis of outcomes after placement.
White RE; Parker RK; Fitzwater JW; Kasepoi Z; Topazian M
Lancet Oncol; 2009 Mar; 10(3):240-6. PubMed ID: 19230771
[TBL] [Abstract][Full Text] [Related]
2. Self-expanding metal stents (SEMS) for patients with advanced esophageal cancer in Malawi: an effective palliative treatment.
Thumbs A; Borgstein E; Vigna L; Kingham TP; Kushner AL; Hellberg K; Bates J; Wilhelm TJ
J Surg Oncol; 2012 Mar; 105(4):410-4. PubMed ID: 22161968
[TBL] [Abstract][Full Text] [Related]
3. Temporary placement of self-expanding oesophageal stents as bridging for neo-adjuvant therapy.
Langer FB; Schoppmann SF; Prager G; Tomaselli F; Pluschnig U; Hejna M; Schmid R; Zacherl J
Ann Surg Oncol; 2010 Feb; 17(2):470-5. PubMed ID: 19859771
[TBL] [Abstract][Full Text] [Related]
4. Outcomes following oesophageal stent insertion for palliation of malignant strictures: A large single centre series.
Battersby NJ; Bonney GK; Subar D; Talbot L; Decadt B; Lynch N
J Surg Oncol; 2012 Jan; 105(1):60-5. PubMed ID: 22161899
[TBL] [Abstract][Full Text] [Related]
5. Severe complications limit long-term clinical success of self-expanding metal stents in patients with obstructive colorectal cancer.
Fernández-Esparrach G; Bordas JM; Giráldez MD; Ginès A; Pellisé M; Sendino O; Martínez-Pallí G; Castells A; Llach J
Am J Gastroenterol; 2010 May; 105(5):1087-93. PubMed ID: 19935785
[TBL] [Abstract][Full Text] [Related]
6. Low morbidity after palliation of obstructing gastro-oesophageal adenocarcinoma to restore swallowing function.
Kofoed SC; Lundsgaard M; Ellemann AC; Svendsen LB
Dan Med J; 2012 Jun; 59(6):A4434. PubMed ID: 22677236
[TBL] [Abstract][Full Text] [Related]
7. Undernutrition is predictive of early mortality after palliative self-expanding metal stent insertion in patients with inoperable or recurrent esophageal cancer.
Lecleire S; Di Fiore F; Antonietti M; Ben Soussan E; Hellot MF; Grigioni S; Déchelotte P; Lerebours E; Michel P; Ducrotté P
Gastrointest Endosc; 2006 Oct; 64(4):479-84. PubMed ID: 16996335
[TBL] [Abstract][Full Text] [Related]
8. Acceptable results after self-expanding metallic stent treatment for dysphagia in non-resectable oesophageal cancer.
Bjerring OS; Pless T; Fristrup C; Mortensen MB
Dan Med J; 2012 Jun; 59(6):A4459. PubMed ID: 22677249
[TBL] [Abstract][Full Text] [Related]
9. Palliation of esophageal carcinoma with a new self-expanding plastic stent.
Dormann AJ; Eisendrath P; Wigginghaus B; Huchzermeyer H; Devière J
Endoscopy; 2003 Mar; 35(3):207-11. PubMed ID: 12584638
[TBL] [Abstract][Full Text] [Related]
10. A randomized prospective comparison of self-expandable plastic stents and partially covered self-expandable metal stents in the palliation of malignant esophageal dysphagia.
Conio M; Repici A; Battaglia G; De Pretis G; Ghezzo L; Bittinger M; Messmann H; Demarquay JF; Blanchi S; Togni M; Conigliaro R; Filiberti R
Am J Gastroenterol; 2007 Dec; 102(12):2667-77. PubMed ID: 18042102
[TBL] [Abstract][Full Text] [Related]
11. Evolving role of self-expanding metal stents in the treatment of malignant dysphagia and fistulas.
Ross WA; Alkassab F; Lynch PM; Ayers GD; Ajani J; Lee JH; Bismar M
Gastrointest Endosc; 2007 Jan; 65(1):70-6. PubMed ID: 17185082
[TBL] [Abstract][Full Text] [Related]
12. Esophageal stents for the relief of malignant dysphagia due to extrinsic compression.
van Heel NC; Haringsma J; Spaander MC; Bruno MJ; Kuipers EJ
Endoscopy; 2010 Jul; 42(7):536-40. PubMed ID: 20432203
[TBL] [Abstract][Full Text] [Related]
13. Palliation of dysphagia from inoperable oesophageal carcinoma using Atkinson tubes or self-expanding metal stents.
Davies N; Thomas HG; Eyre-Brook IA
Ann R Coll Surg Engl; 1998 Nov; 80(6):394-7. PubMed ID: 10209405
[TBL] [Abstract][Full Text] [Related]
14. Impact of nutritional factors on survival in patients with inoperable oesophageal cancer undergoing self-expanding metal stent insertion.
Gray RT; O'donnell ME; Scott RD; McGuigan JA; Mainie I
Eur J Gastroenterol Hepatol; 2011 Jun; 23(6):455-60. PubMed ID: 21505346
[TBL] [Abstract][Full Text] [Related]
15. A pragmatic randomised controlled trial of the cost-effectiveness of palliative therapies for patients with inoperable oesophageal cancer.
Shenfine J; McNamee P; Steen N; Bond J; Griffin SM
Health Technol Assess; 2005 Feb; 9(5):iii, 1-121. PubMed ID: 15717937
[TBL] [Abstract][Full Text] [Related]
16. Comparison of endoscopic laser therapy and self expanding metal stents for palliation in patients with non-resectable oesophageal carcinoma.
Drummond RJ; Vass DG; Robertson K; Sharp C; Gibson S
Surgeon; 2018 Jun; 16(3):137-140. PubMed ID: 28341407
[TBL] [Abstract][Full Text] [Related]
17. Quality of life after palliative treatment for oesophageal carcinoma -- a prospective comparison between stent placement and single dose brachytherapy.
Homs MY; Essink-Bot ML; Borsboom GJ; Steyerberg EW; Siersema PD;
Eur J Cancer; 2004 Aug; 40(12):1862-71. PubMed ID: 15288288
[TBL] [Abstract][Full Text] [Related]
18. Stents for proximal esophageal cancer: a case-control study.
Parker RK; White RE; Topazian M; Chepkwony R; Dawsey S; Enders F
Gastrointest Endosc; 2011 Jun; 73(6):1098-105. PubMed ID: 21295300
[TBL] [Abstract][Full Text] [Related]
19. Management of malignant oesophageal obstruction with self-expanding metallic stents.
Cowling MG; Hale H; Grundy A
Br J Surg; 1998 Feb; 85(2):264-6. PubMed ID: 9501832
[TBL] [Abstract][Full Text] [Related]
20. Prior chemoradiotherapy is associated with a higher life-threatening complication rate after palliative insertion of metal stents in patients with oesophageal cancer.
Lecleire S; Di Fiore F; Ben-Soussan E; Antonietti M; Hellot MF; Paillot B; Lerebours E; Ducrotté P; Michel P
Aliment Pharmacol Ther; 2006 Jun; 23(12):1693-702. PubMed ID: 16817912
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
